Cystitis Treatment With High Dose Chondroitin Sulfate

Patent No. EP1603578 (titled "Cystitis Treatment With High Dose Chondroitin Sulfate") was filed by Aralez Pharmaceuticals Canada on Feb 18, 2004. The application was issued on Oct 29, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IBSA INSTITUT BIOCHIMIQUEJul 23, 2015GERLI
FARCO-PHARMA GMBHJul 9, 2015VON ROHR PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1603578

ARALEZ PHARMACEUTICALS CANADA
Application Number
EP04711966A
Filing Date
Feb 18, 2004
Status
Revoked
Mar 6, 2020
Publication Date
Oct 29, 2014